Enkrisi

ENKRISI - (THE NEW BETTER NORMAL) We provide a capable and dynamic consultancy that stands out from the rest regarding drug development and regulatory affairs within the pharmaceutical industry. Through leveraging data, apps, and platforms with Augmented Intelligence (IA), Enkrisi offers clients an impressive experience backed by experienced human advisors. With their expertise, you can ensure your drugs are optimized for success and make an impact in the life sciences universe. The Regulatory Intelligence of Tomorrow! Regulatory Intelligence is essential for all organizations to stay ahead of the ever-changing regulatory landscape. A modernized approach to regulatory affairs and the development of new technologies and tools for monitoring emerging requirements can help maximize efficiency, reduce licensing timelines, and ensure the accuracy of product details. By investing in advanced regulatory intelligence systems, companies can stay current with impending regulations and remain competitive in their respective industries. Introducing ENKRISI – the leading consulting group helping organizations comply with drug regulations through a comprehensive drug development model incorporating augmented intelligence (AI) and data analytics. Our team of industry experts is equipped to help both emerging biotechs and established pharmaceuticals understand how to use AI and machine learning to stay on top of rapidly changing regulatory requirements. We're here to help navigate the complex world of compliance more manageable than ever! Our Reimagining Regulatory Pathways Services can help you design and implement best practices to streamline your operations and ensure you stay in line with current legislation. We provide a range of services covering technical and strategic aspects of regulatory drug development. Our team can assist with developing an overall strategy that accounts for all potential risks while still being able to meet your objectives.